AMPH vs TMO · P/E 12, rev $732.0M vs P/E 24, rev $44.56B
Amphastar P (AMPH) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the AMPH and TMO stock pages for the full models.
Not investment advice.